According to FutureWise analysis, the market for Aerosol Delivery Devices is expected to reach US$ 57.02 billion by 2031 at a CAGR of 5.12% over the forecast period of 2023-2031.
The delivery of aerosol medication directly to the airways is a mainstay in emergency treatment and long-term management of COPD, asthma, and other chronic lung diseases in adult and pediatric populations. Aerosol delivery devices have been evolved over more than sixty years from the basic pressurized metered-dose inhaler and nebulizer to various types of inhalers and devices, including dry powder inhalers, soft mist inhalers, valved holder chambers, as well as smart inhalers and nebulizers. Although these devices improved patients' ability to self-administer medication, many problems with optimal delivery still need to be solved. Appropriate selection and repeated patient education can lessen the issues with these devices. Understanding the clinical application and science of aerosol drug delivery devices can substantially help clinicians optimize these therapies for their patients. Currently, ultrasonic nebulizers and jets are most widely used to administer mainly antimicrobial drugs against various lung infections, chemotherapeutics for lung cancer treatment, and provocative agents in bronchial challenge tests.
Nebulizers convert solutions or suspensions into aerosols, producing particles of a size suitable for inhalation into the lower respiratory tract. There are ultrasonic nebulizers, pneumatic jet nebulizers, and mesh nebulizers. The latest nebulizer designs are breath-enhanced, breath-actuated, or have aerosol storage bags to minimize aerosol loss during exhalation. Nebulizers can be used with a helium-oxygen mixture and for continuous aerosol delivery. Recently, a growing focus has been on concerns associated with using a facemask alongside a nebulizer. The pressurized metered-dose inhaler (pMDI) is a widely used aerosol delivery device in press-and-breathe and breath-actuated designs. Issues related to pMDIs that include increasing attention are the conversion to hydrofluoroalkane fuel and dose counters. Many patients need better pMDI techniques.
FutureWise Market Research has published a report that provides an insightful analysis aerosol delivery devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, aerosol delivery devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.